Benjamin Jacobs1, Andrea Obi2, Thomas Wakefield2. 1. Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich. Electronic address: benjac@med.umich.edu. 2. Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Mich.
Abstract
OBJECTIVE: Venous thromboembolism (VTE) is a common disease with serious, often fatal sequelae. The optimal strategy for diagnosis of VTE remains unclear, although considerable progress has been made in this area. Several new biomarkers have showed promise for diagnosis of VTE, and more are under active investigation. We reviewed the literature for studies evaluating these diagnostic biomarkers. METHODS: We reviewed the English literature between 1990 and 2015, searching for papers evaluating diagnostic performance of biomarkers in VTE. RESULTS: D-dimer, a fibrin degradation product, has been thoroughly investigated, and performs well in select populations, although it is best as a rule-out test because of its generally low specificity. Soluble P-selectin, a marker of endothelial activation, has shown good diagnostic performance in several studies but has not yet been adopted widely. Others, including cellular adhesion molecules, tissue factor, circulating microparticles, and C-reactive protein, are under investigation, with varying results in a few studies. CONCLUSIONS: At this time, D-dimer and P-selectin remain the most clinically valuable. New biomarkers are needed for clinical use in VTE.
OBJECTIVE:Venous thromboembolism (VTE) is a common disease with serious, often fatal sequelae. The optimal strategy for diagnosis of VTE remains unclear, although considerable progress has been made in this area. Several new biomarkers have showed promise for diagnosis of VTE, and more are under active investigation. We reviewed the literature for studies evaluating these diagnostic biomarkers. METHODS: We reviewed the English literature between 1990 and 2015, searching for papers evaluating diagnostic performance of biomarkers in VTE. RESULTS: D-dimer, a fibrin degradation product, has been thoroughly investigated, and performs well in select populations, although it is best as a rule-out test because of its generally low specificity. Soluble P-selectin, a marker of endothelial activation, has shown good diagnostic performance in several studies but has not yet been adopted widely. Others, including cellular adhesion molecules, tissue factor, circulating microparticles, and C-reactive protein, are under investigation, with varying results in a few studies. CONCLUSIONS: At this time, D-dimer and P-selectin remain the most clinically valuable. New biomarkers are needed for clinical use in VTE.
Authors: Mary Cushman; Geoffrey D Barnes; Mark A Creager; Jose A Diaz; Peter K Henke; Kellie R Machlus; Marvin T Nieman; Alisa S Wolberg Journal: Res Pract Thromb Haemost Date: 2020-07-08
Authors: Katie Harris; Jonathan Michael Laws; Antoine Elias; David Andrew Green; Nandu Goswami; Jens Jordan; Tovy Haber Kamine; Lucia Mazzolai; Lonnie G Petersen; Andrew James Winnard; Tobias Weber Journal: Front Physiol Date: 2022-04-27 Impact factor: 4.755
Authors: Philip Smith; Axel Rosell; Maria Farm; Maria Bruzelius; Katherina Aguilera Gatica; Nigel Mackman; Jacob Odeberg; Charlotte Thålin Journal: PLoS One Date: 2022-07-28 Impact factor: 3.752